Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 45, Issue 7, Pages 1663-1675Publisher
WILEY
DOI: 10.1002/hed.27379
Keywords
access; equity; head and neck cancer; HPV; insurance; Medicare; quality of life
Categories
Ask authors/readers for more resources
Uninsured individuals aged 55-64 have worse outcomes compared to their insured counterparts. Adequate coverage can prevent these delays. This study investigates the impact of Medicare on the diagnosis and treatment of head and neck squamous cell carcinoma (HNSCC).
BackgroundUninsured individuals age 55-64 experience disproportionately poor outcomes compared to their insured counterparts. Adequate coverage may prevent these delays. This study investigates a Medicare-effect on head and neck squamous cell carcinoma (HNSCC) diagnosis and treatment. MethodsThe Surveillance, Epidemiology, and End Results (SEER) database was queried for persons ages 60-70 years in the United States from 2000 to 2016 with HNSCC. A Medicare effect was defined as an increase in incidence, reduction in advanced stage presentation, and/or decrease in cancer-specific mortality (CSM). ResultsCompared to their Medicaid or uninsured counterparts, patients age 65 have an increased incidence of HNSCC diagnosis, reduction in advanced stage presentation, decrease in cancer-specific mortality, and higher likelihood of receiving cancer-specific surgery. ConclusionsPatients age 65 with Medicare have decreased incidence of HNSCC, less hazard of late-stage diagnosis, and lower cancer-specific mortality than their Medicaid or uninsured counterparts, supporting the idea of a Medicare effect in HNSCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available